Visceral fat area predicts survival in patients with advanced hepatocellular carcinoma treated with tyrosine kinase inhibitors

JC Nault, F Pigneur, DR Nelson, C Costentin, L Tselikas, S Katsahian, G Diao, A Laurent, A Mallat, C Duvoux, Alain LUCIANI, T Decaens,

Dig Liver Dis 01/10/2015;47(10) : 869-876 10.1016/j.dld.2015.07.001. 10/07/2015

Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas.

JC Nault, S Datta, S Imbeaud, A Franconi, A Mallat, G Couchy, E Letouze, C Pilati, B Verret, JF Blanc, C Balabaud, Julien CALDERARO, A Laurent, M Letexier, P Bioulac-Sage, F Calvo, J Zucman-Rossi,

Nat Genet 01/10/2015;47(10) : 1187-1193 10.1038/ng.3389 24/08/2015

BRAF V600E mutational status in bile duct adenomas and hamartomas.

A Pujals, P Bioulac-Sage, C Castain, C Charpy, ES Zafrani, Julien CALDERARO,

Histopathology 01/10/2015;67(4) : 562-7 10.1111/his.12674. 31/03/2015

Early virological assessment during telaprevir- or boceprevir-based triple therapy in hepatitis C cirrhotic patients who failed a previous interferon based regimen - The ANRS CO20-CUPIC study.

F Bailly, V Virlogeux, C Dufour, P Pradat, Christophe HEZODE, D Larrey, L Alric, D Samuel, M Bourliere, S Metivier, JP Zarski, H Fontaine, V Loustaud-Ratti, L Serfaty, JP Bronowicki, F Carrat, F Zoulim,

Clin Res Hepatol Gastroenterol. 01/09/2015;39(4) : 443-450 10.1016/j.clinre.2014.12.007 27/01/2015

Resistance to direct-acting antiviral agents: clinical utility and significance.

V Cento, Stephane CHEVALIEZ, CF Perno,

Curr Opin HIV AIDS 01/09/2015;10(5) : 381-389 10.1097/COH.0000000000000177.

Clinical outcomes of right-lobe split-liver versus orthotopic liver transplants from donors more than 70 years old.

R Memeo, N De'Angelis, C Salloum, P Compagnon, A Laurent, Cyrille FERAY, C Duvoux, D Azoulay,

Prog Transplant. 01/09/2015;25(3) : 243-50 10.7182/pit2015303.

Breast tomosynthesis: Dosimetry and image quality assessment on phantom.

E Meyblum, F Gardavaud, T Dao, I Fournier, P Beaussart, F Pigneur, L Baranes, A Rahmouni, Alain LUCIANI,

Diagn Interv Imaging. 01/09/2015;96(9) : 931-939 10.1016/j.diii.2014.12.010 20/04/2015

Randomized controlled trial of the NS5A inhibitor daclatasvir plus pegylated interferon and ribavirin for HCV genotype-4 (COMMAND-4).

Christophe HEZODE, L Alric, A Brown, T Hassanein, M Rizzetto, M Buti, M Bourliere, D Thabut, E Molina, V Rustgi, D Samuel, F McPhee, Z Liu, PD Yin, E Hughes, M Treitel, COMMAND-4 study team

Anticir Ther 27/08/2015;21(3) : 195-205 10.3851/IMP2985.

Identification of a duplicated V3 domain in NS5A associated with cirrhosis and hepatocellular carcinoma in HCV-1b patients.

H Le Guillou-Guillemette, A Ducancelle, S Bertrais, C Lemaire, A Pivert, P Veillon, E Bouthry, S Alain, V Thibault, F Abravanel, AR Rosenberg, C Henquell, E Andre-Garnier, O Petsaris, S Vallet, JB Bour, Y Baazia, P Trimoulet, P Andre, C Gaudy-Graffin, D Bettinger, S Larrat, A Signori-Schmuck, H Saoudin, B Pozzetto, G Lagathu, S Minjolle-Cha, F Stoll-Keller, Jean-Michel PAWLOTSKY, J Izopet, C Payan, F Lunel-Fabiani,

J Clin Virol. 01/08/2015;69 : 203-209 10.1016/j.jcv.2015.06.096 24/06/2015

Use of Model-Based Iterative Reconstruction (MBIR) in reduced-dose CT for routine follow-up of patients with malignant lymphoma: dose savings, image quality and phantom study.

E Herin, F Gardavaud, M Chiaradia, P Beaussart, P Richard, M Cavet, JF Deux, C Haioun, E Itti, A Rahmouni, Alain LUCIANI,

Eur Radiol 01/08/2015;25(8) : 2362-2370 10.1007/s00330-015-3656-9. 08/03/2015